PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9213829-9	1997	Heparansulphate and sulodexide were able to reduce signs and symptoms with similar degree and to significantly modify t-PA, alpha 2-antiplasmin and ATIII levels without any difference between treatments.	glucuronyl glucosamine glycan sulfate	20-30	plasminogen activator, tissue type	Homo sapiens	118-122	
27519200-3	1995	Sulodexide significantly increased t-PA activity linearly with the dose over the range of 50 to 200mg.	glucuronyl glucosamine glycan sulfate	0-10	plasminogen activator, tissue type	Homo sapiens	35-39